Trial Profile

An Exploratory Trial to Evaluate the Clinical Effectiveness of a Topical Application of BMX-010 in Subjects With Rosacea

Status: Suspended

Phase of Trial: Phase II

Latest Information Update: 30 Sep 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs BMX-010 (Primary)
Indications Rosacea
Focus Therapeutic Use
Sponsors BioMimetix

Most Recent Events

26 Sep 2022 Planned End Date changed from 1 Nov 2022 to 1 Mar 2025.
26 Sep 2022 Planned primary completion date changed from 1 Sep 2022 to 1 Sep 2024.
26 Sep 2022 Status changed from active, no longer recruiting to suspended due to re-formulation of study product.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com